{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:47:32Z","timestamp":1791175652925,"version":"4.1.0"},"reference-count":50,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T00:00:00Z","timestamp":1383782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in Western countries. Today, the role of the host\u2019s immune system in controlling the progression and spread of solid tumors is broadly established. Tumor immunosurveillance escape mechanisms, such as those involving dendritic cells (DCs), the most important antigen-presenting cells, are likewise recognized processes involved in cancer. The present study evaluates the ability of CRC patients to generate DCs in vitro from circulating monocytes at both pre- and post-operative timepoints; the results are correlated with the stage of disease to shed light on the systemic immune statuses of CRC patients. Our data showed that patients\u2019 DCs had lower co-stimulatory molecule expression and were less able to present antigens to allogeneic T cells compared to healthy controls\u2019 (HC) DCs. Furthermore altered cytokine secretion, such as increased IL-10 and reduced IL-12 and TNF-\u03b1, was observed. At the post-operative timepoints we observed a recovery of the patients\u2019 ability to generate immature DCs, compared to HCs, but the maturational capacity remained affected. Our study conclusively highlights the persistently impaired in vitro generation of fully mature and functional DCs, which appears to be more altered during advanced stages. This work sheds light on a dendritic cell-based tumor immune  escape mechanism that could be useful for the development of more effective  immunotherapeutic strategies.<\/jats:p>","DOI":"10.3390\/ijms141122022","type":"journal-article","created":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T15:28:06Z","timestamp":1383838086000},"page":"22022-22041","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Defective Generation and Maturation of Dendritic Cells from Monocytes in Colorectal Cancer Patients during the Course  of Disease"],"prefix":"10.3390","volume":"14","author":[{"given":"Giulia","family":"Orsini","sequence":"first","affiliation":[{"name":"Laboratory of Immunology, Department of Clinical and Experimental Medicine, University of Pisa, via Roma, 67, Pisa 56126, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Legitimo","sequence":"additional","affiliation":[{"name":"Laboratory of Immunology, Department of Clinical and Experimental Medicine, University of Pisa, via Roma, 67, Pisa 56126, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Failli","sequence":"additional","affiliation":[{"name":"Laboratory of Immunology, Department of Clinical and Experimental Medicine, University of Pisa, via Roma, 67, Pisa 56126, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Azienda Ospedaliero-Universitaria Pisana (AOUP), via Roma, 67, Pisa 56126, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Nicolini","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Section Medical Oncology, University of Pisa, via Roma, 67, Pisa 56126, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Spisni","sequence":"additional","affiliation":[{"name":"Department of Surgery, Molecular, Medical and Critical Area Pathology, University of Pisa,  via Paradisa, 2, Pisa 56126, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Miccoli","sequence":"additional","affiliation":[{"name":"Department of Surgery, Molecular, Medical and Critical Area Pathology, University of Pisa,  via Paradisa, 2, Pisa 56126, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Consolini","sequence":"additional","affiliation":[{"name":"Laboratory of Immunology, Department of Clinical and Experimental Medicine, University of Pisa, via Roma, 67, Pisa 56126, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2013,11,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1158\/0008-5472.CAN-08-2654","article-title":"Coordination of intratumoral immune reaction and human colorectal cancer recurrence","volume":"69","author":"Camus","year":"2009","journal-title":"Cancer Res"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1040-8428(02)00159-2","article-title":"Immunology and immunotherapy of colorectal cancer","volume":"46","author":"Dalerba","year":"2003","journal-title":"Crit. Rev. Oncol. Hematol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ctrv.2011.09.001","article-title":"The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer","volume":"38","author":"Roxburgh","year":"2012","journal-title":"Cancer Treat. Rev"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Nagorsen, D., Voigt, S., Berg, E., Stein, H., Thiel, E., and Loddenkemper, C. (2007). Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: Relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival. J. Transl. Med, 5.","DOI":"10.1186\/1479-5876-5-62"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00384-011-1334-1","article-title":"Role of dendritic cells in progression and clinical outcome of colon cancer","volume":"27","author":"Gulubova","year":"2012","journal-title":"Int. J. Colorectal Dis"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1600-0625.2008.00823.x","article-title":"Dendritic cells\u2014Why can they help and hurt us","volume":"18","year":"2009","journal-title":"Exp. Dermatol"},{"key":"ref_8","first-page":"16","article-title":"Immunosuppressive networks in the tumour environment and their effect in dendritic cells","volume":"1795","author":"Bennaceur","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.193.2.233","article-title":"Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells","volume":"193","author":"Dhodapkar","year":"2001","journal-title":"J. Exp. Med"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1440-1711.2005.01371.x","article-title":"Dendritic cell dysfunction in cancer: A mechanism for immunosuppression","volume":"83","author":"Maxwell","year":"2005","journal-title":"Immunol. Cell Biol"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1593\/neo.05442","article-title":"A population of HLA-DR+ immature cells accumulates in the blood dendritic cell compartment of patients with different types of cancer","volume":"7","author":"Ho","year":"2005","journal-title":"Neoplasia"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.3748\/wjg.v12.i20.3275","article-title":"Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma","volume":"12","author":"Ormandy","year":"2006","journal-title":"World J. Gastroenterol"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jss.2010.09.027","article-title":"Circulating myeloid dendritic cells as prognostic factors in patients with pancreatic cancer who have undergone surgical resection","volume":"173","author":"Yamamoto","year":"2012","journal-title":"J. Surg. Res"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Orsini, G., Legitimo, A., Failli, A., Ferrari, P., Nicolini, A., Spisni, R., Miccoli, P., and Consolini, R. (2013). Quantification of blood dendritic cells in colorectal cancer patients during the course of disease. Pathol. Oncol. Res.","DOI":"10.1007\/s12253-013-9691-4"},{"key":"ref_16","first-page":"1755","article-title":"Clinical significance of defective dendritic cell differentiation in cancer","volume":"6","author":"Almand","year":"2000","journal-title":"Clin. Cancer Res"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.3748\/wjg.v13.i44.5822","article-title":"Immunotherapy and immunoescape in colorectal cancer","volume":"13","author":"Mazzolini","year":"2007","journal-title":"World J. Gastroenterol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0753-3322(00)80050-5","article-title":"Dysfunctional regulation of the development of monocyte-derived dendritic cells in cancer patients","volume":"54","author":"Hasebe","year":"2000","journal-title":"Biomed. Pharmacother"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/pros.21248","article-title":"Prostatectomy restores the maturation competence of blood dendritic cell precursors and reverses the abnormal expansion of regulatory T lymphocytes","volume":"71","author":"Brusa","year":"2011","journal-title":"Prostate"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5603\/FHC.2011.0022","article-title":"Evaluation of monocyte-derived dendritic cells, T regulatory and Th17 cells in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors","volume":"49","author":"Hus","year":"2011","journal-title":"Folia Histochem. Cytobiol"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.trsl.2011.03.003","article-title":"Defective dendritic cell generation from monocytes is a potential reason for poor therapeutic efficacy of interferon \u03b12b (IFN\u03b12b) in cervical cancer","volume":"158","author":"Roy","year":"2011","journal-title":"Transl. Res"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/2047-783X-16-2-57","article-title":"Dendritic cell generation and CD4+ CD25high FOXP3+ regulatory T cells in human head and neck carcinoma during radio-chemotherapy","volume":"16","author":"Schuler","year":"2011","journal-title":"Eur. J. Med. Res"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00253-012-4034-z","article-title":"Impaired dendritic cell maturation and IL-10 production following H. pylori stimulation in gastric cancer patients","volume":"96","author":"Chang","year":"2012","journal-title":"Appl. Microbiol. Biotechnol"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1189\/jlb.0112048","article-title":"Monocyte-derived dendritic cells from breast cancer patients are biased to induce CD4+CD25+Foxp3+ regulatory T cells","volume":"92","author":"Ramos","year":"2012","journal-title":"J. Leukoc. Biol"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/1097-0142(19890201)63:3<496::AID-CNCR2820630318>3.0.CO;2-K","article-title":"S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis","volume":"63","author":"Ambe","year":"1989","journal-title":"Cancer"},{"key":"ref_26","first-page":"4423","article-title":"Relationships between S-100 protein-positive cells and clinicopathological factors in patients with colorectal cancer","volume":"23","author":"Nakayama","year":"2003","journal-title":"Anticancer Res"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s00262-004-0548-2","article-title":"Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells","volume":"53","author":"Dadabayev","year":"2004","journal-title":"Cancer Immunol. Immunother"},{"key":"ref_28","first-page":"3541","article-title":"Relationship between interleukin-12-expressing cells and antigen-presenting cells in patients with colorectal cancer","volume":"25","author":"Inoue","year":"2005","journal-title":"Anticancer Res"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1158\/1078-0432.CCR-04-1448","article-title":"Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: Role of maturation status and intratumoral localization","volume":"11","author":"Sandel","year":"2005","journal-title":"Clin. Cancer Res"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1600-0463.2008.00879.x","article-title":"Dendritic cell infiltration pattern along the colorectal adenoma-carcinoma sequence","volume":"116","author":"Yuan","year":"2008","journal-title":"APMIS"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/clim.2002.5293","article-title":"Dysfunctional and short-lived subsets in monocyte-derived dendritic cells from patients with advanced cancer","volume":"105","author":"Onishi","year":"2002","journal-title":"Clin. Immunol"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.clim.2006.06.011","article-title":"Role of conventional treatments on circulating and monocyte-derived dendritic cells in colorectal cancer","volume":"121","author":"Bellik","year":"2006","journal-title":"Clin. Immunol"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1158\/0008-5472.CAN-06-4806","article-title":"The adaptive immunologic microenvironment in colorectal cancer: A novel perspective","volume":"67","author":"Galon","year":"2007","journal-title":"Cancer Res"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1200\/JCO.2010.30.5425","article-title":"Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction","volume":"29","author":"Mlecnik","year":"2011","journal-title":"J. Clin. Oncol"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1084\/jem.20111413","article-title":"Ovarian cancer progression is controlled by phenotypic changes in dendritic cells","volume":"209","author":"Scarlett","year":"2012","journal-title":"J. Exp. Med"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.critrevonc.2007.10.002","article-title":"The use of dendritic cells in cancer immunotherapy","volume":"65","author":"Nencioni","year":"2008","journal-title":"Crit. Rev. Oncol. Hematol"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pharmthera.2003.08.003","article-title":"Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: Roles of the receptor complex","volume":"100","author":"Fujihara","year":"2003","journal-title":"Pharmacol. Ther"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/intimm\/12.11.1511","article-title":"Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells","volume":"12","author":"Kato","year":"2000","journal-title":"Int. Immunol"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1172\/JCI39717","article-title":"Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice","volume":"119","author":"Bedoret","year":"2009","journal-title":"J. Clin. Invest"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Schmid, M.C., and Varner, J.A. (2010). Myeloid cells in the tumor microenvironment: Modulation of tumor angiogenesis and tumor inflammation. J. Oncol, 2010.","DOI":"10.1155\/2010\/201026"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e23837","DOI":"10.4161\/onci.23837","article-title":"Functional characterization of a STAT3-dependent dendritic cell-derived CD14(+) cell population arising upon IL-10-driven maturation","volume":"2","author":"Lindenberg","year":"2013","journal-title":"Oncoimmunology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e27944","DOI":"10.1371\/journal.pone.0027944","article-title":"Tumour tissue microenvironment can inhibit dendritic cell maturation in colorectal cancer","volume":"6","author":"Michielsen","year":"2011","journal-title":"PLoS One"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/ni1192","article-title":"Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells","volume":"6","author":"Rimoldi","year":"2005","journal-title":"Nat. Immunol"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-3083.2009.02308.x","article-title":"How do regulatory T cells work?","volume":"70","author":"Corthay","year":"2009","journal-title":"Scand. J. Immunol"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8674(01)00455-X","article-title":"Regulation of T cell immunity by dendritic cells","volume":"106","author":"Lanzavecchia","year":"2001","journal-title":"Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-065X.2008.00718.x","article-title":"Inflammatory signals in dendritic cell activation and the induction of adaptive immunity","volume":"227","author":"Joffre","year":"2009","journal-title":"Immunol. Rev"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1097-0215(19971104)73:3<309::AID-IJC1>3.0.CO;2-3","article-title":"Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma","volume":"73","author":"Enk","year":"1997","journal-title":"Int. J. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.canlet.2013.05.013","article-title":"Numerical defect of circulating dendritic cell subsets and defective dendritic cell generation from monocytes of patients with advanced melanoma","volume":"337","author":"Failli","year":"2013","journal-title":"Cancer Lett"},{"key":"ref_49","first-page":"483","article-title":"Decreased antigen presentation by dendritic cells in patients with breast cancer","volume":"3","author":"Gabrilovich","year":"1997","journal-title":"Clin. Cancer Res"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1258\/ebm.2011.011168","article-title":"Zoledronic acid modulates maturation of human monocyte-derived dendritic cells","volume":"236","author":"Orsini","year":"2011","journal-title":"Exp. Biol. Med. (Maywood)"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/11\/22022\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:50:26Z","timestamp":1760219426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/11\/22022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,7]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11]]}},"alternative-id":["ijms141122022"],"URL":"https:\/\/doi.org\/10.3390\/ijms141122022","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,7]]}}}